Objective: Next-generation sequencing (NGS) is increasingly being employed in the context of personalized cancer treatment. Anticipating unsolicited findings that may arise during a NGS procedure is a key consideration; however, little is known about cancer patients' intentions, needs, and preferences concerning the return of unsolicited findings. Methods: A qualitative design using individual semi-structured interviews with 24 cancer patients was utilized to explore patients' decisions on whether to receive unsolicited findings from NGS. These interviews were subsequently analyzed using the constant comparative method to develop codes and themes. Results: We identified 4 interrelated themes that emerged in the context of the return of unso...
© 2019 The Author(s). Aim: This study explored the attitudes of patients with advanced cancer t...
OBJECTIVES: Germline genome sequencing (GS) is becoming mainstream in cancer diagnosis and risk mana...
Reducing cancer-related uncertainty is a motivating factor for accessing genetic testing, such as te...
The research described in this thesis focuses on cancer patients’ intentions, needs and preferences ...
Next-generation sequencing (NGS) can be used to generate information about a patient's tumour and pe...
BACKGROUND: In precision medicine, somatic and germline DNA sequencing are essential to make genome-...
Unsolicited findings (UFs) in clinical exome sequencing are variants that are unrelated to the initi...
Cancer patients participating in studies involving experimental or diagnostic next-generation sequen...
textabstractCancer patients participating in studies involving experimental or diagnostic next-gener...
© 2015 National Society of Genetic Counselors, Inc. Next generation sequencing (NGS) for patients at...
Objective This study explored family communication about undertaking genomic sequencing, and intenti...
Purpose: Dramatic advances in genomic technology stand to revolutionize cancer care; however, little...
Purpose The introduction of comprehensive tumour genomic profiling (CGP) into clinical oncology allo...
AbstractGermline genome sequencing (GS) holds great promise for cancer prevention by identifying can...
Objective: As large-scale genome sequencing technology advances, concerns surrounding the reporting ...
© 2019 The Author(s). Aim: This study explored the attitudes of patients with advanced cancer t...
OBJECTIVES: Germline genome sequencing (GS) is becoming mainstream in cancer diagnosis and risk mana...
Reducing cancer-related uncertainty is a motivating factor for accessing genetic testing, such as te...
The research described in this thesis focuses on cancer patients’ intentions, needs and preferences ...
Next-generation sequencing (NGS) can be used to generate information about a patient's tumour and pe...
BACKGROUND: In precision medicine, somatic and germline DNA sequencing are essential to make genome-...
Unsolicited findings (UFs) in clinical exome sequencing are variants that are unrelated to the initi...
Cancer patients participating in studies involving experimental or diagnostic next-generation sequen...
textabstractCancer patients participating in studies involving experimental or diagnostic next-gener...
© 2015 National Society of Genetic Counselors, Inc. Next generation sequencing (NGS) for patients at...
Objective This study explored family communication about undertaking genomic sequencing, and intenti...
Purpose: Dramatic advances in genomic technology stand to revolutionize cancer care; however, little...
Purpose The introduction of comprehensive tumour genomic profiling (CGP) into clinical oncology allo...
AbstractGermline genome sequencing (GS) holds great promise for cancer prevention by identifying can...
Objective: As large-scale genome sequencing technology advances, concerns surrounding the reporting ...
© 2019 The Author(s). Aim: This study explored the attitudes of patients with advanced cancer t...
OBJECTIVES: Germline genome sequencing (GS) is becoming mainstream in cancer diagnosis and risk mana...
Reducing cancer-related uncertainty is a motivating factor for accessing genetic testing, such as te...